Indications for HAEGARDA:
Routine prophylaxis to prevent hereditary angioedema (HAE) attacks in patients ≥6yrs.
Adults and Children:
<6yrs: not established. Rotate inj sites. Give by SC inj (eg, abdominal area, other SC sites). ≥6yrs: 60 IU/kg twice weekly (every 3 or 4 days).
Discontinue and treat if severe hypersensitivity reactions occur. Have epinephrine inj available. Risk of thromboembolism events. Contains human plasma; monitor for possible infection transmission (eg, viruses, Creutzfeldt-Jakob disease agent). Elderly. Pregnancy. Nursing mothers.
Inj site reaction, hypersensitivity, nasopharyngitis, dizziness.
To report infections that may have been transmitted by Haegarda, call (866) 915-6958.
Generic Drug Availability: